Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Braggio

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Nature Communications|May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humansFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Blood Cancer Journal|November 23, 2022
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosisSameer A Parikh, Sara J Achenbach, Kari G Rabe, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell LymphocytosisBryan A Vallejo, Ahmed Ansari, Sameer A Parikh, et al.
British Journal of Haematology|July 16, 2022
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemiaPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Blood|April 14, 2012
Clonal competition with alternating dominance in multiple myelomaJonathan J Keats, Marta Chesi, Jan B Egan, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Nature Communications|May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humansFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Blood Cancer Journal|November 23, 2022
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosisSameer A Parikh, Sara J Achenbach, Kari G Rabe, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell LymphocytosisBryan A Vallejo, Ahmed Ansari, Sameer A Parikh, et al.
British Journal of Haematology|July 16, 2022
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemiaPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Blood|April 14, 2012
Clonal competition with alternating dominance in multiple myelomaJonathan J Keats, Marta Chesi, Jan B Egan, et al.
Pageof 15